started · updated
CDC report identifies 19 drug-resistant pathogens as major health threats
A new report from the Centers for Disease Control and Prevention (CDC) identifies 19 bacteria and fungi that pose varying levels of threat to human health due to antimicrobial resistance (AMR). The pathogens, which range from “concerning” to “urgent” threats, are causing an estimated 9.7 million infections and 50,800 deaths in the United States annually.
The report highlights that these pathogens have mutated to the point where existing antimicrobial drugs are often ineffective. While many of these threats were previously associated with hospitalized patients, they are increasingly causing infections in individuals receiving care outside of hospital settings.
Experts note that the market for developing new antimicrobials is currently dysfunctional. Because new drugs must be used judiciously to maintain efficacy, biotechnology companies struggle to recoup investments, leading to many innovations failing or companies facing bankruptcy. Advocates suggest policy solutions, such as the PASTEUR Act, are necessary to encourage the development of new treatments to combat this growing threat.
Entities
Biotechnology Innovation Organization · Centers for Disease Control and Prevention · United States · University at Buffalo